OPY Acquisition Corp. I

A blank check company formed to effect a business combination in the healthcare industry

About Us

We are a blank check company formed as a Delaware corporation for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar transaction with one or more businesses, which we refer to throughout this prospectus as our initial business combination. Our efforts to identify a prospective target business will not be limited to any particular industry or geographic region, although, initially, we intend to pursue targets in the life sciences industry with a primary focus on novel therapeutics, medical devices or services that help improve healthcare outcomes, areas in which our management team, directors and advisors have extensive experience. We believe that the opportunity set of potential targets is significant, and we intend to focus on assets based in the US, Europe and Israel.

Our sponsor is controlled and managed by Oppenheimer Alternative Investment Management LLC, an affiliate of Oppenheimer & Co. Inc., a global full-service brokerage and investment bank. We believe our management team’s background, and Oppenheimer’s unique sourcing infrastructure provide us with the ability to identify attractive transactions and target businesses. Oppenheimer brings a unique expertise in the healthcare space with significant transaction experience and wide coverage of both private and public healthcare companies.

Meet the team

Company Contact

85 Broad Street
New York, NY 10004

(212) 668-8000